Načítá se...
Personalized Therapy for Acute Myeloid Leukemia
Patient specific ex-vivo drug sensitivity and resistance screening can identify rational drug candidates for testing of personalized targeted therapy. An iterative approach of genomic and drug susceptibility characterization at sequential time-points during clinical trials of targeted therapy in AML...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3880545/ https://ncbi.nlm.nih.gov/pubmed/24327695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-13-0832 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|